iwNHL 2016 highlights: CAR T-cell therapy, DLBCL and new technologies
The changing definition of complete remission in multiple myeloma
Carlos Fernandez de Larrea
Daratumumab in multiple myeloma: an overview of 3 key trials
Niels van de Donk
What are the practical considerations for monoclonal antibody infusion?
Improving the outcomes of transplantation with bispecific antibodies